Evaluation of the 50% Infectious Dose of Human Norovirus Cin-2 in Gnotobiotic Pigs: A Comparison of Classical and Contemporary Methods for Endpoint Estimation

Human Norovirus: Experimental Models of Infection

(2019) Kyle Todd et al.   Viruses-Basel

Persistence of Antibodies to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: 1-Year Follow-up With Memory Probe Vaccination

(2019) Robert L Atmar et al.   JOURNAL OF INFECTIOUS DISEASES

Assessment of replicate numbers for titrating avian influenza virus using dose-response models

(2019) Erica Spackman et al.   JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION

Animals as Reservoir for Human Norovirus

(2019) Nele Villabruna et al.   Viruses-Basel

Recognizing Structural Nonidentifiability: When Experiments Do Not Provide Information About Important Parameters and Misleading Models Can Still Have Great Fit

(2019) Philip J. Schmidt et al.   RISK ANALYSIS

Enhanced GII.4 human norovirus infection in gnotobiotic pigs transplanted with a human gut microbiota

(2019) Shaohua Lei et al.   JOURNAL OF GENERAL VIROLOGY

A rapid method for titration of ascovirus infectivity

(2018) Ningning Han et al.   JOURNAL OF VIROLOGICAL METHODS

Vesicle-Cloaked Virus Clusters Are Optimal Units for Inter-organismal Viral Transmission

(2018) Marianita Santiana et al.   Cell Host & Microbe

Development of a microbial dose response visualization and modelling application for QMRA modelers and educators

(2017) Mark H. Weir et al.   ENVIRONMENTAL MODELLING & SOFTWARE

Lithium chloride inhibits early stages of foot-and-mouth disease virus (FMDV) replication in vitro

(2017) Fu-Rong Zhao et al.   JOURNAL OF MEDICAL VIROLOGY

Norovirus Infection and Acquired Immunity in 8 Countries: Results From the MAL-ED Study

(2016) Saba Rouhani et al.   CLINICAL INFECTIOUS DISEASES

Increased and prolonged human norovirus infection in RAG2/IL2RG deficient gnotobiotic pigs with severe combined immunodeficiency

(2016) Shaohua Lei et al.   Scientific Reports

Enterobacter cloacae inhibits human norovirus infectivity in gnotobiotic pigs

(2016) Shaohua Lei et al.   Scientific Reports

High Protective Efficacy of Probiotics and Rice Bran against Human Norovirus Infection and Diarrhea in Gnotobiotic Pigs

(2016) Shaohua Lei et al.   Frontiers in Microbiology

Noroviruses: epidemiology, immunity and prospects for prevention

(2015) Kimberly Pringle et al.   Future Microbiology

Large Animal Models for Vaccine Development and Testing

(2015) V. Gerdts et al.   ILAR JOURNAL

Emergence in Taiwan of novel norovirus GII.4 variants causing acute gastroenteritis and intestinal haemorrhage in children

(2015) Shih-Yen Chen et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Robust mucosal-homing antibody-secreting B cell responses induced by intramuscular administration of adjuvanted bivalent human norovirus-like particle vaccine

(2015) Aarthi Sundararajan et al.   VACCINE

World Health Organization Estimates of the Global and Regional Disease Burden of 22 Foodborne Bacterial, Protozoal, and Viral Diseases, 2010: A Data Synthesis

(2015) Martyn D. Kirk et al.   PLOS MEDICINE

Parsimonious Determination of the Optimal Infectious Dose of a Pathogen for Nonhuman Primate Models

(2015) Mario Roederer   PLoS Pathogens

Genetic Analysis of Norovirus GII.4 Variant Strains Detected in Outbreaks of Gastroenteritis in Yokohama, Japan, from the 2006-2007 to the 2013-2014 Seasons

(2015) Makoto Kumazaki et al.   PLoS One

Norovirus Vaccine Against Experimental Human GII.4 Virus Illness: A Challenge Study in Healthy Adults

(2014) D. I. Bernstein et al.   JOURNAL OF INFECTIOUS DISEASES

A Novel Intramuscular Bivalent Norovirus Virus-Like Particle Vaccine Candidate—Reactogenicity, Safety, and Immunogenicity in a Phase 1 Trial in Healthy Adults

(2014) John J. Treanor et al.   JOURNAL OF INFECTIOUS DISEASES

Intranasal P Particle Vaccine Provided Partial Cross-Variant Protection against Human GII.4 Norovirus Diarrhea in Gnotobiotic Pigs

(2014) J. Kocher et al.   JOURNAL OF VIROLOGY

Norovirus Dose-Response: Are Currently Available Data Informative Enough to Determine How Susceptible Humans Are to Infection from a Single Virus?

(2014) Philip J. Schmidt   RISK ANALYSIS

Fractional Poisson-A Simple Dose-Response Model for Human Norovirus

(2014) Michael J. Messner et al.   RISK ANALYSIS

Median infectious dose of human norovirus GII.4 in gnotobiotic pigs is decreased by simvastatin treatment and increased by age

(2013) T. Bui et al.   JOURNAL OF GENERAL VIROLOGY

Determination of the 50% Human Infectious Dose for Norwalk Virus

(2013) Robert L. Atmar et al.   JOURNAL OF INFECTIOUS DISEASES

Norovirus and Medically Attended Gastroenteritis in U.S. Children

(2013) Daniel C. Payne et al.   NEW ENGLAND JOURNAL OF MEDICINE

Harnessing the Theoretical Foundations of the Exponential and Beta-Poisson Dose-Response Models to Quantify Parameter Uncertainty Using Markov Chain Monte Carlo

(2013) Philip J. Schmidt et al.   RISK ANALYSIS

A Mouse Model for Human Norovirus

(2013) S. Taube et al.   mBio

Comparison of Norovirus RNA Levels in Outbreak-Related Oysters with Background Environmental Levels

(2012) JAMES A. LOWTHER et al.   JOURNAL OF FOOD PROTECTION

Predicting Susceptibility to Norovirus GII.4 by Use of a Challenge Model Involving Humans

(2012) R. Frenck et al.   JOURNAL OF INFECTIOUS DISEASES

Infection of Calves with Bovine Norovirus GIII.1 Strain Jena Virus: an Experimental Model To Study the Pathogenesis of Norovirus Infection

(2011) P. H. Otto et al.   JOURNAL OF VIROLOGY

Norovirus Vaccine against Experimental Human Norwalk Virus Illness

(2011) Robert L. Atmar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comprehensive Analysis of a Norovirus-Associated Gastroenteritis Outbreak, from the Environment to the Consumer

(2010) Françoise S. Le Guyader et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Chimpanzees as an animal model for human norovirus infection and vaccine development

(2010) K. Bok et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Epidemics of Gastroenteritis during 2006 Were Associated with the Spread of Norovirus GII.4 Variants 2006a and 2006b

(2008) E. T.- V. Tu et al.   CLINICAL INFECTIOUS DISEASES

Norwalk virus: How infectious is it?

(2008) Peter F.M. Teunis et al.   JOURNAL OF MEDICAL VIROLOGY